Article Details

Generalized Myasthenia Gravis Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical ...

Retrieved on: 2024-05-08 18:43:07

Tags for this article:

Click the tags to see associated articles and topics

Generalized Myasthenia Gravis Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical .... View article details on hiswai:

Excerpt

... Roche, Janssen Research & Development, Immunovant Sciences GmbH, Bristol Myers Squibb, Biogen Inc., Pfizer, Novartis, Sanofi, Roche, Johnson ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo